Aro Biotherapeutics Patents – Insights & Stats (Updated 2023)

Aro Biotherapeutics has a total of 41 patents globally, out of which 2 have been granted. Of these 41 patents, more than 82% patents are active. The United States of America is where Aro Biotherapeutics has filed the maximum number of patents. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Aro Biotherapeutics.

Aro Biotherapeutics was founded in 2017. Aro Biotherapeutics is a biotechnology company that specializes in the investigation and creation of novel protein biologics. It offers services in the areas of oncology, siRNA, immunology, bispecific, protein conjugation, protein therapies, licensing, drug delivery, and protein engineering.

Do read about some of the most popular patents of Aro Biotherapeutics which have been covered by us in this article and also you can find Aro Biotherapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Aro Biotherapeutics patent portfolio.

How many patents does Aro Biotherapeutics have?

Aro Biotherapeutics has a total of 41 patents globally. These patents belong to 11 unique patent families. Out of 41 patents, 34 patents are active.

How Many Patents did Aro Biotherapeutics File Every Year?

Aro Biotherapeutics Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantAro Biotherapeutics Applications FiledAro Biotherapeutics Patents Granted
202362
202214
20216
202015

How many Aro Biotherapeutics patents are Alive/Dead?

Worldwide Patents

Aro Biotherapeutics Patent Portfolio

How Many Patents did Aro Biotherapeutics File in Different Countries?

Aro Biotherapeutics Worldwide Patent Filing

Countries in which Aro Biotherapeutics Filed Patents

CountryPatents
United States Of America7
Australia4
Canada4
Hong Kong (S.A.R.)4
China3
Europe3
New Zealand3
South Africa2
Taiwan2

Where are Research Centers of Aro Biotherapeutics Patents Located?

R&D Centres of Aro Biotherapeutics

10 Best Aro Biotherapeutics Patents

US11628222B2, US20220332795A1 are the most popular patents in the Aro Biotherapeutics portfolio they have received 1 citation.

List of Aro Biotherapeutics patents

Aro Biotherapeutics PatentsTitle
US11781138B2Fn3 Domain-Sirna Conjugates And Uses Thereof
US11628222B2Cd71 Binding Fibronectin Type Iii Domains
US20230330239A1Epcam Binding Fibronectin Type Iii Domains
US20230183314A1Prostate Specific Membrane Antigen Binding Fibronectin Type Iii Domains And Cells Comprising The Same
US20230039851A1Serum Albumin-Binding Fibronectin Type Iii Domains And Uses Thereof
US20220370626A1Fn3 Domain-Sirna Conjugates And Uses Thereof
US20220332795A1Cd71 Binding Fibronectin Type Iii Domains
EP4146805A2Prostate Specific Membrane Antigen Binding Fibronectin Type Iii Domains And Cells Comprising The Same
EP4076505A1Serum Albumin-Binding Fibronectin Type Iii Domains And Uses Thereof
EP4045061A1Cd71 Binding Fibronectin Type Iii Domains
CN115884778AFibronectin Type Iii Domains Binding To Prostate-Specific Membrane Antigens And Cells Comprising Same
CN115175691ASerum Albumin Binding Fibronectin Type Iii Domains And Uses Thereof
CN114786682AFibronectin Type Iii Domains That Bind Cd71
WO2023201362A2Fn3 Domain-Sirna Conjugates With Enzyme Replacement Therapy
WO2023003874A3Human Fibronectin Type Iii Protein Scaffolds
CA3214552A1Cd71 Binding Fibronectin Type Iii Domains
CA3215367A1Fn3 Domain-Sirna Conjugates And Uses Thereof
CA3177330A1Prostate Specific Membrane Antigen Binding Fibronectin Type Iii Domains And Cells Comprising The Same
CA3161723A1Serum Albumin-Binding Fibronectin Type Iii Domains And Uses Thereof
AU2022258584A1Fn3 Domain-Sirna Conjugates And Uses Thereof
AU2022258566A1Cd71 Binding Fibronectin Type Iii Domains
AU2021266735A1Prostate Specific Membrane Antigen Binding Fibronectin Type Iii Domains And Cells Comprising The Same
AU2020405107A1Serum Albumin-Binding Fibronectin Type Iii Domains And Uses Thereof
ZA202309758ACd71 Binding Fibronectin Type Iii Domains
ZA202309611AFn3 Domain-Sirna Conjugates And Uses Thereof
HK40083231ASerum Albumin-Binding Fibronectin Type Iii Domains And Uses Thereof
HK40081011ASerum Albumin-Binding Fibronectin Type Iii Domains And Uses Thereof
HK40079223ACd71 Binding Fibronectin Type Iii Domains
HK40076447ACd71 Binding Fibronectin Type Iii Domains
TW202304519AFn3 Domain-Sirna Conjugates And Uses Thereof
TW202304971ACd71 Binding Fibronectin Type Iii Domains
NZ804071AFn3 Domain-Sirna Conjugates And Uses Thereof
NZ804153ACd71 Binding Fibronectin Type Iii Domains
NZ789645ASerum Albumin-Binding Fibronectin Type Iii Domains And Uses Thereof
WO2022221505A3Cd71 Binding Fibronectin Type Iii Domains
WO2022221550A1Fn3 Domain-Sirna Conjugates And Uses Thereof
WO2021226223A3Prostate Specific Membrane Antigen Binding Fibronectin Type Iii Domains And Cells Comprising The Same
WO2021127353A1Serum Albumin-Binding Fibronectin Type Iii Domains And Uses Thereof
WO2021076546A9Cd71 Binding Fibronectin Type Iii Domains
WO2021076574A3Fn3 Domain-Sirna Conjugates And Uses Thereof
WO2021076543A1Epcam Binding Fibronectin Type Iii Domains

What are Aro Biotherapeutics key innovation segments?

What Technologies are Covered by Aro Biotherapeutics?

The chart below distributes patents filed by Aro Biotherapeutics in different countries on the basis of the technology protected in patents. It also represents the markets where Aro Biotherapeutics thinks it’s important to protect particular technology inventions.

R&D Focus: How has Aro Biotherapeutics search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Aro Biotherapeutics?

Related Articles

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.